2-Aminoindane: Difference between revisions
>Kaylee |
>Kaylee |
||
Line 39: | Line 39: | ||
*'''[[Effect::Cognitive euphoria|Euphoria]]''' | *'''[[Effect::Cognitive euphoria|Euphoria]]''' | ||
*'''[[Effect::Compulsive redosing]]''' | *'''[[Effect::Compulsive redosing]]''' | ||
===Visual effects=== | ===Visual effects=== | ||
*'''[[Effect::Acuity enhancement]]''' | *'''[[Effect::Acuity enhancement]]''' | ||
===After effects=== | |||
The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. Its effects commonly include: | |||
*'''[[Effect::Cognitive fatigue]]''' | |||
*'''[[Effect::Thought deceleration]]''' | |||
*'''[[Effect::Anxiety]]''' | |||
*'''[[Effect::Depression]]''' | |||
*'''[[Effect::Wakefulness]]''' | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== |